 | • レポートコード：QYR9ST00658 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の組換え治療用抗体及びタンパク質市場について調査・分析し、以下の構成でお届け致します。組換え治療用抗体及びタンパク質の種類別には、血漿タンパク質、融合タンパク質、モノクローナル抗体、ホルモン、酵素、凝固因子、その他に、用途別には、腫瘍学、血液学、免疫学、内分泌学、感染症、心血管疾患、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別組換え治療用抗体及びタンパク質売上データ ・地域別組換え治療用抗体及びタンパク質市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別組換え治療用抗体及びタンパク質市場規模：血漿タンパク質、融合タンパク質、モノクローナル抗体、ホルモン、酵素、凝固因子、その他 ・用途別組換え治療用抗体及びタンパク質市場規模：腫瘍学、血液学、免疫学、内分泌学、感染症、心血管疾患、その他 ・主要メーカーの企業情報：Abbott、Amgen、Biogen、Eli Lilly、Roche、Johnson and Johnson、Merck、Novo Nordisk、Pfizer、Sanofi ・組換え治療用抗体及びタンパク質の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Therapeutic proteins are engineered in the laboratory for pharmaceutical use, including non-covalent binders. These proteins are highly effective and serve as modernized treatment for rare as well as chronic diseases. Protein therapeutics offer custom-made treatment approach by supporting a specifically targeted therapeutic process by compensating the deficiency of an essential protein. Recombinant proteins have gained significant traction for therapeutic applications and the number of proteins either launched or approved into clinical trials has continually increased over the past two decades. According to the National Center for Biotechnology Information (NCBI) data of 2017, the U.S. Food and Drug Administration (FDA) approved over 140 recombinant therapeutic proteins for human use and several hundred are currently in development. Majority of these proteins are recombinant monoclonal antibodies.The global recombinant therapeutic antibodies and proteins market size was valued at US$ 92.5 billion in 2017, and is expected to witness a robust CAGR of 11.2% over the forecast period (2017 – 2025).
The global Recombinant Therapeutic Antibodies and Proteins market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Recombinant Therapeutic Antibodies and Proteins market based on company, product type, end user and key regions.
This report studies the global market size of Recombinant Therapeutic Antibodies and Proteins in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Recombinant Therapeutic Antibodies and Proteins in these regions.
This research report categorizes the global Recombinant Therapeutic Antibodies and Proteins market by top players/brands, region, type and end user. This report also studies the global Recombinant Therapeutic Antibodies and Proteins market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Abbott
Amgen
Biogen
Eli Lilly
Roche
Johnson and Johnson
Merck
Novo Nordisk
Pfizer
Sanofi
Market size by Product
Plasma Protein
Fusion Proteins
Monoclonal Antibodies
Hormones
Enzyme
Coagulation Factors
Others
Market size by End User
Oncology
Hematology
Immunology
Endocrinology
Infectious Disease
Cardiovascular Disease
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Recombinant Therapeutic Antibodies and Proteins market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Recombinant Therapeutic Antibodies and Proteins market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Recombinant Therapeutic Antibodies and Proteins companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Recombinant Therapeutic Antibodies and Proteins submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Recombinant Therapeutic Antibodies and Proteins are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Recombinant Therapeutic Antibodies and Proteins market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Recombinant Therapeutic Antibodies and Proteins Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Recombinant Therapeutic Antibodies and Proteins Market Size Growth Rate by Product
1.4.2 Plasma Protein
1.4.3 Fusion Proteins
1.4.4 Monoclonal Antibodies
1.4.5 Hormones
1.4.6 Enzyme
1.4.7 Coagulation Factors
1.4.8 Others
1.5 Market by End User
1.5.1 Global Recombinant Therapeutic Antibodies and Proteins Market Size Growth Rate by End User
1.5.2 Oncology
1.5.3 Hematology
1.5.4 Immunology
1.5.5 Endocrinology
1.5.6 Infectious Disease
1.5.7 Cardiovascular Disease
1.5.8 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Recombinant Therapeutic Antibodies and Proteins Market Size
2.1.1 Global Recombinant Therapeutic Antibodies and Proteins Revenue 2014-2025
2.1.2 Global Recombinant Therapeutic Antibodies and Proteins Sales 2014-2025
2.2 Recombinant Therapeutic Antibodies and Proteins Growth Rate by Regions
2.2.1 Global Recombinant Therapeutic Antibodies and Proteins Sales by Regions
2.2.2 Global Recombinant Therapeutic Antibodies and Proteins Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Recombinant Therapeutic Antibodies and Proteins Sales by Manufacturers
3.1.1 Recombinant Therapeutic Antibodies and Proteins Sales by Manufacturers
3.1.2 Recombinant Therapeutic Antibodies and Proteins Sales Market Share by Manufacturers
3.1.3 Global Recombinant Therapeutic Antibodies and Proteins Market Concentration Ratio (CR5 and HHI)
3.2 Recombinant Therapeutic Antibodies and Proteins Revenue by Manufacturers
3.2.1 Recombinant Therapeutic Antibodies and Proteins Revenue by Manufacturers (2014-2019)
3.2.2 Recombinant Therapeutic Antibodies and Proteins Revenue Share by Manufacturers (2014-2019)
3.3 Recombinant Therapeutic Antibodies and Proteins Price by Manufacturers
3.4 Recombinant Therapeutic Antibodies and Proteins Manufacturing Base Distribution, Product Types
3.4.1 Recombinant Therapeutic Antibodies and Proteins Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Recombinant Therapeutic Antibodies and Proteins Product Type
3.4.3 Date of International Manufacturers Enter into Recombinant Therapeutic Antibodies and Proteins Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Recombinant Therapeutic Antibodies and Proteins Sales by Product
4.2 Global Recombinant Therapeutic Antibodies and Proteins Revenue by Product
4.3 Recombinant Therapeutic Antibodies and Proteins Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Recombinant Therapeutic Antibodies and Proteins Breakdown Data by End User
6 North America
6.1 North America Recombinant Therapeutic Antibodies and Proteins by Countries
6.1.1 North America Recombinant Therapeutic Antibodies and Proteins Sales by Countries
6.1.2 North America Recombinant Therapeutic Antibodies and Proteins Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Recombinant Therapeutic Antibodies and Proteins by Product
6.3 North America Recombinant Therapeutic Antibodies and Proteins by End User
7 Europe
7.1 Europe Recombinant Therapeutic Antibodies and Proteins by Countries
7.1.1 Europe Recombinant Therapeutic Antibodies and Proteins Sales by Countries
7.1.2 Europe Recombinant Therapeutic Antibodies and Proteins Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Recombinant Therapeutic Antibodies and Proteins by Product
7.3 Europe Recombinant Therapeutic Antibodies and Proteins by End User
8 Asia Pacific
8.1 Asia Pacific Recombinant Therapeutic Antibodies and Proteins by Countries
8.1.1 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Sales by Countries
8.1.2 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Recombinant Therapeutic Antibodies and Proteins by Product
8.3 Asia Pacific Recombinant Therapeutic Antibodies and Proteins by End User
9 Central & South America
9.1 Central & South America Recombinant Therapeutic Antibodies and Proteins by Countries
9.1.1 Central & South America Recombinant Therapeutic Antibodies and Proteins Sales by Countries
9.1.2 Central & South America Recombinant Therapeutic Antibodies and Proteins Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Recombinant Therapeutic Antibodies and Proteins by Product
9.3 Central & South America Recombinant Therapeutic Antibodies and Proteins by End User
10 Middle East and Africa
10.1 Middle East and Africa Recombinant Therapeutic Antibodies and Proteins by Countries
10.1.1 Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Sales by Countries
10.1.2 Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Recombinant Therapeutic Antibodies and Proteins by Product
10.3 Middle East and Africa Recombinant Therapeutic Antibodies and Proteins by End User
11 Company Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Company Business Overview
11.1.3 Abbott Recombinant Therapeutic Antibodies and Proteins Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Abbott Recombinant Therapeutic Antibodies and Proteins Products Offered
11.1.5 Abbott Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Company Business Overview
11.2.3 Amgen Recombinant Therapeutic Antibodies and Proteins Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Amgen Recombinant Therapeutic Antibodies and Proteins Products Offered
11.2.5 Amgen Recent Development
11.3 Biogen
11.3.1 Biogen Company Details
11.3.2 Company Business Overview
11.3.3 Biogen Recombinant Therapeutic Antibodies and Proteins Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Biogen Recombinant Therapeutic Antibodies and Proteins Products Offered
11.3.5 Biogen Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Company Business Overview
11.4.3 Eli Lilly Recombinant Therapeutic Antibodies and Proteins Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Eli Lilly Recombinant Therapeutic Antibodies and Proteins Products Offered
11.4.5 Eli Lilly Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Company Business Overview
11.5.3 Roche Recombinant Therapeutic Antibodies and Proteins Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Roche Recombinant Therapeutic Antibodies and Proteins Products Offered
11.5.5 Roche Recent Development
11.6 Johnson and Johnson
11.6.1 Johnson and Johnson Company Details
11.6.2 Company Business Overview
11.6.3 Johnson and Johnson Recombinant Therapeutic Antibodies and Proteins Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Johnson and Johnson Recombinant Therapeutic Antibodies and Proteins Products Offered
11.6.5 Johnson and Johnson Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Company Business Overview
11.7.3 Merck Recombinant Therapeutic Antibodies and Proteins Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Merck Recombinant Therapeutic Antibodies and Proteins Products Offered
11.7.5 Merck Recent Development
11.8 Novo Nordisk
11.8.1 Novo Nordisk Company Details
11.8.2 Company Business Overview
11.8.3 Novo Nordisk Recombinant Therapeutic Antibodies and Proteins Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Novo Nordisk Recombinant Therapeutic Antibodies and Proteins Products Offered
11.8.5 Novo Nordisk Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Company Business Overview
11.9.3 Pfizer Recombinant Therapeutic Antibodies and Proteins Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Pfizer Recombinant Therapeutic Antibodies and Proteins Products Offered
11.9.5 Pfizer Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Company Business Overview
11.10.3 Sanofi Recombinant Therapeutic Antibodies and Proteins Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Sanofi Recombinant Therapeutic Antibodies and Proteins Products Offered
11.10.5 Sanofi Recent Development
12 Future Forecast
12.1 Recombinant Therapeutic Antibodies and Proteins Market Forecast by Regions
12.1.1 Global Recombinant Therapeutic Antibodies and Proteins Sales Forecast by Regions 2019-2025
12.1.2 Global Recombinant Therapeutic Antibodies and Proteins Revenue Forecast by Regions 2019-2025
12.2 Recombinant Therapeutic Antibodies and Proteins Market Forecast by Product
12.2.1 Global Recombinant Therapeutic Antibodies and Proteins Sales Forecast by Product 2019-2025
12.2.2 Global Recombinant Therapeutic Antibodies and Proteins Revenue Forecast by Product 2019-2025
12.3 Recombinant Therapeutic Antibodies and Proteins Market Forecast by End User
12.4 North America Recombinant Therapeutic Antibodies and Proteins Forecast
12.5 Europe Recombinant Therapeutic Antibodies and Proteins Forecast
12.6 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Forecast
12.7 Central & South America Recombinant Therapeutic Antibodies and Proteins Forecast
12.8 Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Recombinant Therapeutic Antibodies and Proteins Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Recombinant Therapeutic Antibodies and Proteins Product Picture
Table Recombinant Therapeutic Antibodies and Proteins Market Segments
Table Key Manufacturers Recombinant Therapeutic Antibodies and Proteins Covered
Table Global Recombinant Therapeutic Antibodies and Proteins Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Recombinant Therapeutic Antibodies and Proteins Sales Market Share by Product 2014-2025
Figure Plasma Protein Product Picture
Table Major Manufacturers of Plasma Protein
Figure Fusion Proteins Product Picture
Table Major Manufacturers of Fusion Proteins
Figure Monoclonal Antibodies Product Picture
Table Major Manufacturers of Monoclonal Antibodies
Figure Hormones Product Picture
Table Major Manufacturers of Hormones
Figure Enzyme Product Picture
Table Major Manufacturers of Enzyme
Figure Coagulation Factors Product Picture
Table Major Manufacturers of Coagulation Factors
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Recombinant Therapeutic Antibodies and Proteins Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Oncology
Figure Hematology
Figure Immunology
Figure Endocrinology
Figure Infectious Disease
Figure Cardiovascular Disease
Figure Others
Figure Recombinant Therapeutic Antibodies and Proteins Report Years Considered
Figure Global Recombinant Therapeutic Antibodies and Proteins Market Size 2014-2025 (Million US$)
Figure Global Recombinant Therapeutic Antibodies and Proteins Sales 2014-2025 (K Units)
Table Global Recombinant Therapeutic Antibodies and Proteins Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Recombinant Therapeutic Antibodies and Proteins Sales by Regions 2014-2019 (K Units)
Table Global Recombinant Therapeutic Antibodies and Proteins Sales Market Share by Regions 2014-2019
Figure Global Recombinant Therapeutic Antibodies and Proteins Sales Market Share by Regions 2014-2019
Figure 2018 Global Recombinant Therapeutic Antibodies and Proteins Sales Market Share by Regions
Table Global Recombinant Therapeutic Antibodies and Proteins Revenue by Regions 2014-2019 (Million US$)
Table Global Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Regions 2014-2019
Figure Global Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Regions 2014-2019
Figure 2018 Global Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Regions
Table Global Recombinant Therapeutic Antibodies and Proteins Sales by Manufacturers (2014-2019) (K Units)
Table Global Recombinant Therapeutic Antibodies and Proteins Sales Share by Manufacturers (2014-2019)
Figure Global Recombinant Therapeutic Antibodies and Proteins Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Recombinant Therapeutic Antibodies and Proteins Revenue by Manufacturers (2014-2019) (Million USD)
Table Recombinant Therapeutic Antibodies and Proteins Revenue Share by Manufacturers (2014-2019)
Figure Recombinant Therapeutic Antibodies and Proteins Value Share by Manufacturers in 2018
Table Key Manufacturers Recombinant Therapeutic Antibodies and Proteins Price (2014-2019) (USD/Unit)
Table Recombinant Therapeutic Antibodies and Proteins Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Recombinant Therapeutic Antibodies and Proteins Product Type
Table Date of International Manufacturers Enter into Recombinant Therapeutic Antibodies and Proteins Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Recombinant Therapeutic Antibodies and Proteins Sales by Product (2014-2019) (K Units)
Table Global Recombinant Therapeutic Antibodies and Proteins Sales Share by Product (2014-2019)
Figure Global Recombinant Therapeutic Antibodies and Proteins Sales Market Share by Product (2014-2019)
Figure Global Recombinant Therapeutic Antibodies and Proteins Sales Market Share by Product in 2018
Table Global Recombinant Therapeutic Antibodies and Proteins Revenue by Product (2014-2019) (Million US$)
Table Global Recombinant Therapeutic Antibodies and Proteins Revenue Share by Product (2014-2019)
Figure Global Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Product (2014-2019)
Figure Global Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Product in 2018
Table Recombinant Therapeutic Antibodies and Proteins Price by Product 2014-2019 (USD/Unit)
Table Global Recombinant Therapeutic Antibodies and Proteins Sales by End User (2014-2019) (K Units)
Table Global Recombinant Therapeutic Antibodies and Proteins Sales Share by End User (2014-2019)
Figure Global Sales Recombinant Therapeutic Antibodies and Proteins Market Share by End User (2014-2019)
Figure Global Sales Recombinant Therapeutic Antibodies and Proteins Market Share by End User in 2018
Figure North America Recombinant Therapeutic Antibodies and Proteins Sales Growth Rate 2014-2019 (K Units)
Figure North America Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate 2014-2019 (Million US$)
Table North America Recombinant Therapeutic Antibodies and Proteins Sales by Countries (2014-2019) (K Units)
Table North America Recombinant Therapeutic Antibodies and Proteins Sales Market Share by Countries (2014-2019)
Figure 2018 North America Recombinant Therapeutic Antibodies and Proteins Sales Market Share by Countries
Table North America Recombinant Therapeutic Antibodies and Proteins Revenue by Countries (2014-2019) (Million US$)
Table North America Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Countries
Figure United States Recombinant Therapeutic Antibodies and Proteins Sales Growth Rate (2014-2019) (K Units)
Figure United States Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Recombinant Therapeutic Antibodies and Proteins Sales Growth Rate (2014-2019) (K Units)
Figure Canada Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Recombinant Therapeutic Antibodies and Proteins Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate (2014-2019) (Million US$)
Table North America Recombinant Therapeutic Antibodies and Proteins Sales by Product (2014-2019) (K Units)
Table North America Recombinant Therapeutic Antibodies and Proteins Sales Market Share by Product (2014-2019)
Figure 2018 North America Recombinant Therapeutic Antibodies and Proteins Market Share by Product
Table North America Recombinant Therapeutic Antibodies and Proteins Sales by End User (2014-2019) (K Units)
Table North America Recombinant Therapeutic Antibodies and Proteins Sales Market Share by End User (2014-2019)
Figure 2018 North America Recombinant Therapeutic Antibodies and Proteins Market Share by End User
Figure Europe Recombinant Therapeutic Antibodies and Proteins Sales Growth Rate 2014-2019 (K Units)
Figure Europe Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Recombinant Therapeutic Antibodies and Proteins Sales by Countries (2014-2019) (K Units)
Table Europe Recombinant Therapeutic Antibodies and Proteins Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Recombinant Therapeutic Antibodies and Proteins Sales Market Share by Countries
Table Europe Recombinant Therapeutic Antibodies and Proteins Revenue by Countries (2014-2019) (Million US$)
Table Europe Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Countries
Figure Germany Recombinant Therapeutic Antibodies and Proteins Sales Growth Rate (2014-2019) (K Units)
Figure Germany Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate (2014-2019) (Million US$)
Figure France Recombinant Therapeutic Antibodies and Proteins Sales Growth Rate (2014-2019) (K Units)
Figure France Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Recombinant Therapeutic Antibodies and Proteins Sales Growth Rate (2014-2019) (K Units)
Figure UK Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Recombinant Therapeutic Antibodies and Proteins Sales Growth Rate (2014-2019) (K Units)
Figure Italy Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Recombinant Therapeutic Antibodies and Proteins Sales Growth Rate (2014-2019) (K Units)
Figure Russia Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Recombinant Therapeutic Antibodies and Proteins Sales by Product (2014-2019) (K Units)
Table Europe Recombinant Therapeutic Antibodies and Proteins Sales Market Share by Product (2014-2019)
Figure 2018 Europe Recombinant Therapeutic Antibodies and Proteins Market Share by Product
Table Europe Recombinant Therapeutic Antibodies and Proteins Sales by End User (2014-2019) (K Units)
Table Europe Recombinant Therapeutic Antibodies and Proteins Sales Market Share by End User (2014-2019)
Figure 2018 Europe Recombinant Therapeutic Antibodies and Proteins Market Share by End User
Figure Asia Pacific Recombinant Therapeutic Antibodies and Proteins Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Recombinant Therapeutic Antibodies and Proteins Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Recombinant Therapeutic Antibodies and Proteins Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Sales Market Share by Countries
Table Asia Pacific Recombinant Therapeutic Antibodies and Proteins Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Countries
Figure China Recombinant Therapeutic Antibodies and Proteins Sales Growth Rate (2014-2019) (K Units)
Figure China Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Recombinant Therapeutic Antibodies and Proteins Sales Growth Rate (2014-2019) (K Units)
Figure Japan Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Recombinant Therapeutic Antibodies and Proteins Sales Growth Rate (2014-2019) (K Units)
Figure Korea Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate (2014-2019) (Million US$)
Figure India Recombinant Therapeutic Antibodies and Proteins Sales Growth Rate (2014-2019) (K Units)
Figure India Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Recombinant Therapeutic Antibodies and Proteins Sales Growth Rate (2014-2019) (K Units)
Figure Australia Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Recombinant Therapeutic Antibodies and Proteins Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Recombinant Therapeutic Antibodies and Proteins Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Recombinant Therapeutic Antibodies and Proteins Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Recombinant Therapeutic Antibodies and Proteins Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Recombinant Therapeutic Antibodies and Proteins Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Recombinant Therapeutic Antibodies and Proteins Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Recombinant Therapeutic Antibodies and Proteins Sales by Product (2014-2019) (K Units)
Table Asia Pacific Recombinant Therapeutic Antibodies and Proteins Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Market Share by Product
Table Asia Pacific Recombinant Therapeutic Antibodies and Proteins Sales by End User (2014-2019) (K Units)
Table Asia Pacific Recombinant Therapeutic Antibodies and Proteins Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Market Share by End User
Figure Central & South America Recombinant Therapeutic Antibodies and Proteins Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Recombinant Therapeutic Antibodies and Proteins Sales by Countries (2014-2019) (K Units)
Table Central & South America Recombinant Therapeutic Antibodies and Proteins Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Recombinant Therapeutic Antibodies and Proteins Sales Market Share by Countries
Table Central & South America Recombinant Therapeutic Antibodies and Proteins Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Countries
Figure Brazil Recombinant Therapeutic Antibodies and Proteins Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Recombinant Therapeutic Antibodies and Proteins Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Recombinant Therapeutic Antibodies and Proteins Sales by Product (2014-2019) (K Units)
Table Central & South America Recombinant Therapeutic Antibodies and Proteins Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Recombinant Therapeutic Antibodies and Proteins Market Share by Product
Table Central & South America Recombinant Therapeutic Antibodies and Proteins Sales by End User (2014-2019) (K Units)
Table Central & South America Recombinant Therapeutic Antibodies and Proteins Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Recombinant Therapeutic Antibodies and Proteins Market Share by End User
Figure Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Sales Market Share by Countries
Table Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Countries
Figure GCC Countries Recombinant Therapeutic Antibodies and Proteins Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Recombinant Therapeutic Antibodies and Proteins Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Recombinant Therapeutic Antibodies and Proteins Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Recombinant Therapeutic Antibodies and Proteins Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Market Share by Product
Table Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Market Share by End User
Table Abbott Company Details
Table Abbott Recombinant Therapeutic Antibodies and Proteins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Abbott Recent Development
Table Amgen Company Details
Table Amgen Recombinant Therapeutic Antibodies and Proteins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Amgen Recent Development
Table Biogen Company Details
Table Biogen Recombinant Therapeutic Antibodies and Proteins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Biogen Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Recombinant Therapeutic Antibodies and Proteins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Eli Lilly Recent Development
Table Roche Company Details
Table Roche Recombinant Therapeutic Antibodies and Proteins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Roche Recent Development
Table Johnson and Johnson Company Details
Table Johnson and Johnson Recombinant Therapeutic Antibodies and Proteins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson and Johnson Recent Development
Table Merck Company Details
Table Merck Recombinant Therapeutic Antibodies and Proteins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Recent Development
Table Novo Nordisk Company Details
Table Novo Nordisk Recombinant Therapeutic Antibodies and Proteins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novo Nordisk Recent Development
Table Pfizer Company Details
Table Pfizer Recombinant Therapeutic Antibodies and Proteins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Sanofi Company Details
Table Sanofi Recombinant Therapeutic Antibodies and Proteins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Recent Development
Table Global Recombinant Therapeutic Antibodies and Proteins Sales Forecast by Regions 2019-2025 (K Units)
Table Global Recombinant Therapeutic Antibodies and Proteins Sales Market Share Forecast by Regions 2019-2025
Table Global Recombinant Therapeutic Antibodies and Proteins Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Recombinant Therapeutic Antibodies and Proteins Revenue Market Share Forecast by Regions 2019-2025
Table Global Recombinant Therapeutic Antibodies and Proteins Sales Forecast by Product 2019-2025 (K Units)
Table Global Recombinant Therapeutic Antibodies and Proteins Sales Market Share Forecast by Product 2019-2025
Table Global Recombinant Therapeutic Antibodies and Proteins Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Recombinant Therapeutic Antibodies and Proteins Revenue Market Share Forecast by Product 2019-2025
Table Global Recombinant Therapeutic Antibodies and Proteins Sales Forecast by End User 2019-2025 (K Units)
Table Global Recombinant Therapeutic Antibodies and Proteins Sales Market Share Forecast by End User 2019-2025
Figure North America Recombinant Therapeutic Antibodies and Proteins Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Recombinant Therapeutic Antibodies and Proteins Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Recombinant Therapeutic Antibodies and Proteins Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Recombinant Therapeutic Antibodies and Proteins Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Recombinant Therapeutic Antibodies and Proteins Value Chain
Table Recombinant Therapeutic Antibodies and Proteins Customers List
Table Recombinant Therapeutic Antibodies and Proteins Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
がんモノクローナル抗体の世界市場：インサイト・予測 The mAbs, which are produced by genetic engineering, target antigens in cells, tissues, and organs. They are used in clinical applications to treat diseases with excellent efficacy and minimal side effects. Their MOA, absence of generic pathway, and therapeutic applications distinguish them from oth…- 世界の精製ヒトプロテイン市場：専門的調査 Purified Human Proteins applied in Native antigens for optimized antibody production, Positive controls in ELISA and other antibody assays, Protein-protein interaction, in vitro biochemical assays and cell-based functional assays, Heavy labeled protein as SRM/MRM standards and other in vitro diagnos…
- 世界の精製ヒトプロテイン市場：専門的調査 Purified Human Proteins applied in Native antigens for optimized antibody production, Positive controls in ELISA and other antibody assays, Protein-protein interaction, in vitro biochemical assays and cell-based functional assays, Heavy labeled protein as SRM/MRM standards and other in vitro diagnos…
- 世界の組換え血漿タンパク質治療薬市場：専門的調査 Recombinant plasma protein therapeutics market is driven by various factors such as shift from use of plasma-derived proteins to recombinant therapies, rise in awareness about rare disease management and increased focus on investments in rare diseases.Rising demand from Asia-Pacific region is a majo…
- 乳がんモノクローナル抗体の世界市場：市場規模・現状・予測 Breast cancer is characterized by the malignancy of cells in the tissues of the breast. HER-2 breast cancer is the most common type of breast cancer. The HER-2 protein, present on the surface of normal breast cells, affects the growth of the malignant cells. The uncontrolled synthesis of this protei…